pentobarbital has been researched along with Delirium of Mixed Origin in 5 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Excerpt | Relevance | Reference |
---|---|---|
"Neuroinflammation is associated with the development of hypoactive delirium, which results in poor clinical outcomes." | 5.72 | Yokukansan suppresses neuroinflammation in the hippocampus of mice and decreases the duration of lipopolysaccharide- and diazepam-mediated loss of righting reflex induced by pentobarbital. ( Ishida, T; Jobu, K; Kawada, K; Kawazoe, T; Miyamura, M; Morisawa, S; Nishida, M; Nishimura, S; Tamura, N; Yoshioka, S, 2022) |
"Pentobarbital has been shown to reduce the time to sleep onset, decrease the number of body movements during sleep and spontaneous awakenings and increase the total sleep time." | 5.40 | The use of pentobarbital in cases of severe delirium: a case series. ( Hang, PC; Holahan, T; Kerr, CW; Luczkiewicz, DL; Milch, R, 2014) |
"Neuroinflammation is associated with the development of hypoactive delirium, which results in poor clinical outcomes." | 1.72 | Yokukansan suppresses neuroinflammation in the hippocampus of mice and decreases the duration of lipopolysaccharide- and diazepam-mediated loss of righting reflex induced by pentobarbital. ( Ishida, T; Jobu, K; Kawada, K; Kawazoe, T; Miyamura, M; Morisawa, S; Nishida, M; Nishimura, S; Tamura, N; Yoshioka, S, 2022) |
"Pentobarbital has been shown to reduce the time to sleep onset, decrease the number of body movements during sleep and spontaneous awakenings and increase the total sleep time." | 1.40 | The use of pentobarbital in cases of severe delirium: a case series. ( Hang, PC; Holahan, T; Kerr, CW; Luczkiewicz, DL; Milch, R, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Kawada, K | 1 |
Ishida, T | 1 |
Jobu, K | 1 |
Morisawa, S | 1 |
Kawazoe, T | 1 |
Nishida, M | 1 |
Nishimura, S | 1 |
Tamura, N | 1 |
Yoshioka, S | 1 |
Miyamura, M | 1 |
Kerr, CW | 1 |
Luczkiewicz, DL | 1 |
Holahan, T | 1 |
Milch, R | 1 |
Hang, PC | 1 |
Raft, DD | 1 |
Newmark, C | 1 |
Toomey, T | 1 |
Dobkin, J | 1 |
Isaac, M | 1 |
Pandit, SK | 1 |
Dundee, JW | 1 |
Galway, JE | 1 |
5 other studies available for pentobarbital and Delirium of Mixed Origin
Article | Year |
---|---|
Yokukansan suppresses neuroinflammation in the hippocampus of mice and decreases the duration of lipopolysaccharide- and diazepam-mediated loss of righting reflex induced by pentobarbital.
Topics: Animals; Delirium; Diazepam; Drugs, Chinese Herbal; Glycyrrhizic Acid; Hippocampus; Inflammation; In | 2022 |
The use of pentobarbital in cases of severe delirium: a case series.
Topics: Aged, 80 and over; Delirium; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Palliative | 2014 |
The organic brain syndrome.
Topics: Alcoholic Intoxication; Attention; Chlordiazepoxide; Delirium; Haloperidol; Humans; Hydrocephalus; M | 1974 |
Effects of excitation and anaesthesia on the glutamine content of the rat brain with a reference to the administration of glutamine.
Topics: Ammonia; Animals; Aspartic Acid; Brain; Brain Chemistry; Delirium; Glutamates; Glutamine; Head; Huma | 1972 |
Intravenous ethanol anaesthesia. A study of sequelae and their implications.
Topics: Alcohol Deterrents; Alcoholic Intoxication; Amnesia; Anesthesia, Intravenous; Atropine; Barbiturates | 1971 |